Kushtrim Kryeziu

1.2k total citations
25 papers, 846 citations indexed

About

Kushtrim Kryeziu is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Kushtrim Kryeziu has authored 25 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Kushtrim Kryeziu's work include Colorectal Cancer Treatments and Studies (5 papers), Cancer Genomics and Diagnostics (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Kushtrim Kryeziu is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Cancer Genomics and Diagnostics (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Kushtrim Kryeziu collaborates with scholars based in Austria, Norway and Japan. Kushtrim Kryeziu's co-authors include Petra Heffeter, Walter Berger, Ragnhild A. Lothe, Anita Sveen, Jarle Bruun, Bernhard K. Keppler, Christian R. Kowol, Wilfried Körner, Diana Groza and Tormod Kyrre Guren and has published in prestigious journals such as Angewandte Chemie International Edition, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Kushtrim Kryeziu

24 papers receiving 835 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kushtrim Kryeziu Austria 15 412 344 185 120 85 25 846
Marija Mojić Serbia 18 319 0.8× 273 0.8× 173 0.9× 80 0.7× 65 0.8× 40 950
Carmen A. Widmer Switzerland 3 320 0.8× 318 0.9× 127 0.7× 75 0.6× 71 0.8× 3 698
Boris Cvek Czechia 12 311 0.8× 352 1.0× 220 1.2× 90 0.8× 33 0.4× 22 842
Ravi Thakur India 18 202 0.5× 466 1.4× 209 1.1× 107 0.9× 214 2.5× 36 1.2k
Qianqian Yu China 21 218 0.5× 552 1.6× 102 0.6× 98 0.8× 92 1.1× 37 1.0k
Lynn M. Pouliot United States 5 338 0.8× 566 1.6× 121 0.7× 237 2.0× 66 0.8× 5 893
Dongfan Song China 18 353 0.9× 390 1.1× 193 1.0× 46 0.4× 65 0.8× 32 910
C. Manzotti Italy 16 660 1.6× 480 1.4× 358 1.9× 73 0.6× 61 0.7× 32 1.1k
Liang Xiong China 6 307 0.7× 626 1.8× 191 1.0× 143 1.2× 127 1.5× 10 1.1k
Yunlong Lu China 17 426 1.0× 263 0.8× 377 2.0× 46 0.4× 106 1.2× 29 954

Countries citing papers authored by Kushtrim Kryeziu

Since Specialization
Citations

This map shows the geographic impact of Kushtrim Kryeziu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kushtrim Kryeziu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kushtrim Kryeziu more than expected).

Fields of papers citing papers by Kushtrim Kryeziu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kushtrim Kryeziu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kushtrim Kryeziu. The network helps show where Kushtrim Kryeziu may publish in the future.

Co-authorship network of co-authors of Kushtrim Kryeziu

This figure shows the co-authorship network connecting the top 25 collaborators of Kushtrim Kryeziu. A scholar is included among the top collaborators of Kushtrim Kryeziu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kushtrim Kryeziu. Kushtrim Kryeziu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Omori, Yasufumi, Vigdis Sørensen, Kushtrim Kryeziu, et al.. (2024). The E3 ubiquitin ligase ITCH negatively regulates intercellular communication via gap junctions by targeting connexin43 for lysosomal degradation. Cellular and Molecular Life Sciences. 81(1). 171–171. 3 indexed citations
2.
Omori, Yasufumi, Vigdis Sørensen, Kushtrim Kryeziu, et al.. (2023). Endocytic trafficking of connexins in cancer pathogenesis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(7). 166812–166812. 4 indexed citations
3.
Groza, Diana, Hemma Schueffl, Alessio Terenzi, et al.. (2023). A novel EGFR inhibitor acts as potent tool for hypoxia-activated prodrug systems and exerts strong synergistic activity with VEGFR inhibition in vitro and in vivo. Cancer Letters. 565. 216237–216237. 8 indexed citations
4.
Kryeziu, Kushtrim, Christian H. Bergsland, Marianne G. Guren, et al.. (2021). Increased sensitivity to SMAC mimetic LCL161 identified by longitudinal ex vivo pharmacogenomics of recurrent, KRAS mutated rectal cancer liver metastases. Journal of Translational Medicine. 19(1). 384–384. 10 indexed citations
5.
Sveen, Anita, Bjarne Johannessen, Ina A. Eilertsen, et al.. (2021). The expressed mutational landscape of microsatellite stable colorectal cancers. Genome Medicine. 13(1). 142–142. 4 indexed citations
6.
Kryeziu, Kushtrim, Kaja C. G. Berg, Ina A. Eilertsen, et al.. (2020). Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity. EBioMedicine. 59. 102923–102923. 27 indexed citations
7.
Kryeziu, Kushtrim, Jarle Bruun, Tormod Kyrre Guren, Anita Sveen, & Ragnhild A. Lothe. (2019). Combination therapies with HSP90 inhibitors against colorectal cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1871(2). 240–247. 87 indexed citations
8.
Sveen, Anita, Jarle Bruun, Peter W. Eide, et al.. (2017). Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies. Clinical Cancer Research. 24(4). 794–806. 173 indexed citations
9.
Traxl, Alexander, Thomas Wanek, Kushtrim Kryeziu, et al.. (2017). [ 11 C]Erlotinib PET cannot detect acquired erlotinib resistance in NSCLC tumor xenografts in mice. Nuclear Medicine and Biology. 52. 7–15. 6 indexed citations
10.
Mohr, Thomas, Christine Pirker, Kushtrim Kryeziu, et al.. (2017). Sensitivity towards the GRP78 inhibitor KP1339/IT-139 is characterized by apoptosis induction via caspase 8 upon disruption of ER homeostasis. Cancer Letters. 404. 79–88. 44 indexed citations
11.
Kryeziu, Kushtrim, Diana Groza, Markus Schosserer, et al.. (2017). Long-term exposure of immortalized keratinocytes to arsenic induces EMT, impairs differentiation in organotypic skin models and mimics aspects of human skin derangements. Archives of Toxicology. 92(1). 181–194. 29 indexed citations
12.
Hoda, Mir Alireza, Christine Pirker, Karin Schelch, et al.. (2016). Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro. Molecular Cancer Therapeutics. 15(10). 2357–2369. 17 indexed citations
13.
Henke, Helena, Kushtrim Kryeziu, Sarah Theiner, et al.. (2016). Macromolecular Pt(IV) Prodrugs from Poly(organo)phosphazenes. Macromolecular Bioscience. 16(8). 1239–1249. 22 indexed citations
14.
Kryeziu, Kushtrim, Christine Pirker, Bernhard Englinger, et al.. (2016). Chronic arsenic trioxide exposure leads to enhanced aggressiveness via Met oncogene addiction in cancer cells. Oncotarget. 7(19). 27379–27393. 6 indexed citations
15.
Kljun, Jakob, Kushtrim Kryeziu, Rostyslav Panchuk, et al.. (2015). Structure-Related Mode-of-Action Differences of Anticancer Organoruthenium Complexes with β-Diketonates. Journal of Medicinal Chemistry. 58(9). 3984–3996. 77 indexed citations
16.
Groza, Diana, Kushtrim Kryeziu, Verena Pichler, et al.. (2014). Tumor‐Targeting of EGFR Inhibitors by Hypoxia‐Mediated Activation. Angewandte Chemie International Edition. 53(47). 12930–12935. 61 indexed citations
17.
Kryeziu, Kushtrim, Ute Jungwirth, Mir Alireza Hoda, et al.. (2013). Synergistic Anticancer Activity of Arsenic Trioxide with Erlotinib Is Based on Inhibition of EGFR-Mediated DNA Double-Strand Break Repair. Molecular Cancer Therapeutics. 12(6). 1073–1084. 44 indexed citations
18.
Heffeter, Petra, Kushtrim Kryeziu, Diana Groza, et al.. (2013). The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo. European Journal of Cancer. 49(15). 3366–3375. 73 indexed citations
19.
Fischer, Britta, Petra Heffeter, Kushtrim Kryeziu, et al.. (2013). Poly(lactic acid) nanoparticles of the lead anticancer ruthenium compound KP1019 and its surfactant-mediated activation. Dalton Transactions. 43(3). 1096–1104. 34 indexed citations
20.
Dornetshuber-Fleiss, Rita, Petra Heffeter, Thomas Mohr, et al.. (2013). Destruxins: Fungal-derived cyclohexadepsipeptides with multifaceted anticancer and antiangiogenic activities. Biochemical Pharmacology. 86(3). 361–377. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marija Mojić Breakdown of academic impact, for papers by Carmen A. Widmer Breakdown of academic impact, for papers by Boris Cvek Breakdown of academic impact, for papers by Ravi Thakur Breakdown of academic impact, for papers by Qianqian Yu Breakdown of academic impact, for papers by Lynn M. Pouliot Breakdown of academic impact, for papers by Dongfan Song Breakdown of academic impact, for papers by C. Manzotti Breakdown of academic impact, for papers by Liang Xiong Breakdown of academic impact, for papers by Yunlong Lu
Rankless by CCL
2026